StockData
Rapport Therapeutics, Inc. logo

Rapport Therapeutics, Inc. (RAPP) income statement

RAPPNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 4, 2026Score 7/30
$23.16−0.43 (-1.82%)

Close on Nov 20, 2026Market cap $1.11BP/E –Yield –

See a number that looks wrong?